[
  {
    "ts": "2025-11-05T12:51:24+00:00",
    "headline": "Charles River Laboratories’s (NYSE:CRL) Q3: Beats On Revenue",
    "summary": "Lab services company Charles River Laboratories (NYSE:CRL) announced better-than-expected revenue in Q3 CY2025, but sales were flat year on year at $1.00 billion. Its non-GAAP profit of $2.43 per share was 3.9% above analysts’ consensus estimates.",
    "url": "https://finance.yahoo.com/news/charles-river-laboratories-nyse-crl-125124330.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "ca5e71d9-567e-3374-8de9-0a16ab1b4b0b",
      "content": {
        "id": "ca5e71d9-567e-3374-8de9-0a16ab1b4b0b",
        "contentType": "STORY",
        "title": "Charles River Laboratories’s (NYSE:CRL) Q3: Beats On Revenue",
        "description": "",
        "summary": "Lab services company Charles River Laboratories (NYSE:CRL) announced better-than-expected revenue in Q3 CY2025, but sales were flat year on year at $1.00 billion. Its non-GAAP profit of $2.43 per share was 3.9% above analysts’ consensus estimates.",
        "pubDate": "2025-11-05T12:51:24Z",
        "displayTime": "2025-11-05T12:51:24Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/7509c571642c6ae9d1577bc3c4457c17",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "CRL Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PLZRbui545u2bOcqTkunEw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/7509c571642c6ae9d1577bc3c4457c17.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YlRDliezLyxJ3r.biO59fw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/7509c571642c6ae9d1577bc3c4457c17.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-nyse-crl-125124330.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-nyse-crl-125124330.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T12:22:36+00:00",
    "headline": "Charles River: Q3 Earnings Snapshot",
    "summary": "CRL) on Wednesday reported third-quarter profit of $54.4 million. The Wilmington, Massachusetts-based company said it had profit of $1.10 per share. Earnings, adjusted for non-recurring costs, came to $2.43 per share.",
    "url": "https://finance.yahoo.com/news/charles-river-q3-earnings-snapshot-122236252.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "7a25a8af-db89-3ac7-ada2-c4b3765974b7",
      "content": {
        "id": "7a25a8af-db89-3ac7-ada2-c4b3765974b7",
        "contentType": "STORY",
        "title": "Charles River: Q3 Earnings Snapshot",
        "description": "",
        "summary": "CRL) on Wednesday reported third-quarter profit of $54.4 million. The Wilmington, Massachusetts-based company said it had profit of $1.10 per share. Earnings, adjusted for non-recurring costs, came to $2.43 per share.",
        "pubDate": "2025-11-05T12:22:36Z",
        "displayTime": "2025-11-05T12:22:36Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-q3-earnings-snapshot-122236252.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-q3-earnings-snapshot-122236252.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T12:01:00+00:00",
    "headline": "Charles River Laboratories Provides Update on Strategic Review",
    "summary": "WILMINGTON, Mass., November 05, 2025--Charles River Laboratories Provides Update on Strategic Review",
    "url": "https://finance.yahoo.com/news/charles-river-laboratories-provides-strategic-120100725.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "d97f7225-cd03-3be1-8ab9-939f11afb565",
      "content": {
        "id": "d97f7225-cd03-3be1-8ab9-939f11afb565",
        "contentType": "STORY",
        "title": "Charles River Laboratories Provides Update on Strategic Review",
        "description": "",
        "summary": "WILMINGTON, Mass., November 05, 2025--Charles River Laboratories Provides Update on Strategic Review",
        "pubDate": "2025-11-05T12:01:00Z",
        "displayTime": "2025-11-05T12:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/95963f50be840bc32308be0ab07dd248",
          "originalWidth": 1245,
          "originalHeight": 326,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FYxwMfUk71u1mNTH5BGuKw--~B/aD0zMjY7dz0xMjQ1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/95963f50be840bc32308be0ab07dd248.cf.webp",
              "width": 1245,
              "height": 326,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cRo9EFRHdy8IetEemkKhpQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/95963f50be840bc32308be0ab07dd248.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-provides-strategic-120100725.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-provides-strategic-120100725.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T12:00:00+00:00",
    "headline": "Charles River Laboratories Announces Third-Quarter 2025 Results",
    "summary": "WILMINGTON, Mass., November 05, 2025--Charles River Laboratories Announces Third-Quarter 2025 Results",
    "url": "https://finance.yahoo.com/news/charles-river-laboratories-announces-third-120000309.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "c1719d22-a727-3b62-b386-c1c7c0511812",
      "content": {
        "id": "c1719d22-a727-3b62-b386-c1c7c0511812",
        "contentType": "STORY",
        "title": "Charles River Laboratories Announces Third-Quarter 2025 Results",
        "description": "",
        "summary": "WILMINGTON, Mass., November 05, 2025--Charles River Laboratories Announces Third-Quarter 2025 Results",
        "pubDate": "2025-11-05T12:00:00Z",
        "displayTime": "2025-11-05T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/f9403ee22ba56bc0588346bd9f1f91b6",
          "originalWidth": 1245,
          "originalHeight": 326,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ioc5VflCYY4UFcbBiayyPg--~B/aD0zMjY7dz0xMjQ1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f9403ee22ba56bc0588346bd9f1f91b6.cf.webp",
              "width": 1245,
              "height": 326,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/B39999pqUCKaD2wfLsxwQQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f9403ee22ba56bc0588346bd9f1f91b6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-announces-third-120000309.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-announces-third-120000309.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T13:10:02+00:00",
    "headline": "Charles River Laboratories (CRL) Q3 Earnings and Revenues Surpass Estimates",
    "summary": "Charles River (CRL) delivered earnings and revenue surprises of +4.74% and +2.06%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finance.yahoo.com/news/charles-river-laboratories-crl-q3-131002388.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "3649bcb2-0c4b-39dd-a0b6-149771043995",
      "content": {
        "id": "3649bcb2-0c4b-39dd-a0b6-149771043995",
        "contentType": "STORY",
        "title": "Charles River Laboratories (CRL) Q3 Earnings and Revenues Surpass Estimates",
        "description": "",
        "summary": "Charles River (CRL) delivered earnings and revenue surprises of +4.74% and +2.06%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?",
        "pubDate": "2025-11-05T13:10:02Z",
        "displayTime": "2025-11-05T13:10:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781",
          "originalWidth": 900,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uV6mPOIlsfK8Kl7nmlunJw--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781.cf.webp",
              "width": 900,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sc4z8_.3guA7NR27rd8O3A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-crl-q3-131002388.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-crl-q3-131002388.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]